Macquarie Group’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-36,330
Closed -$1.74M 2075
2024
Q1
$1.74M Sell
36,330
-99,292
-73% -$5.79M ﹤0.01% 1264
2023
Q4
$9.99M Buy
135,622
+272
+0.2% +$18.4K 0.01% 824
2023
Q3
$9.89M Sell
135,350
-468
-0.3% -$37.4K 0.01% 784
2023
Q2
$11.3M Buy
135,818
+9,733
+8% +$852K 0.01% 761
2023
Q1
$11.2M Buy
126,085
+39,544
+46% +$3.44M 0.01% 787
2022
Q4
$7.41M Sell
86,541
-4,011
-4% -$340K 0.01% 900
2022
Q3
$6.5M Buy
90,552
+4,188
+5% +$375K 0.01% 934
2022
Q2
$8.39M Buy
86,364
+7,257
+9% +$740K 0.01% 916
2022
Q1
$8.9K Buy
79,107
+31,243
+65% +$3.33M 0.01% 961
2021
Q4
$6.46M Sell
47,864
-933
-2% -$130K 0.01% 1056
2021
Q3
$6.89M Sell
48,797
-1,312
-3% -$176K 0.01% 1018
2021
Q2
$6.42M Sell
50,109
-544
-1% -$64K 0.01% 1056
2021
Q1
$6.48M Buy
50,653
+8,883
+21% +$1.64M 0.01% 841
2020
Q4
$7.5M Buy
41,770
+14,303
+52% +$3.18M 0.01% 786
2020
Q3
$6.03M Sell
27,467
-258,391
-90% -$57.7M 0.01% 766
2020
Q2
$64M Sell
285,858
-596,029
-68% -$93.4M 0.11% 205
2020
Q1
$86.3M Sell
881,887
-152,904
-15% -$12.4M 0.18% 106
2019
Q4
$77.6M Buy
1,034,791
+8,391
+0.8% +$542K 0.11% 181
2019
Q3
$63M Sell
1,026,400
-49,387
-5% -$2.97M 0.11% 199
2019
Q2
$63.8M Buy
1,075,787
+71,392
+7% +$4.28M 0.11% 198
2019
Q1
$65.8M Buy
1,004,395
+52,544
+6% +$3.18M 0.11% 178
2018
Q4
$46.5M Sell
951,851
-11,668
-1% -$696K 0.09% 230
2018
Q3
$62.8M Buy
963,519
+131,980
+16% +$9.23M 0.1% 199
2018
Q2
$55.3M Sell
831,539
-279,776
-25% -$16.9M 0.1% 206
2018
Q1
$57.6M Sell
1,111,315
-21,428
-2% -$997K 0.1% 187
2017
Q4
$49.1M Buy
1,132,743
+128,081
+13% +$5.23M 0.09% 222
2017
Q3
$44.1M Sell
1,004,662
-287,830
-22% -$10M 0.08% 233
2017
Q2
$35.1M Buy
1,292,492
+96,565
+8% +$2.39M 0.06% 286
2017
Q1
$27.1M Buy
1,195,927
+228,515
+24% +$4.73M 0.05% 376
2016
Q4
$20.7M Buy
967,412
+67,663
+8% +$1.45M 0.04% 425
2016
Q3
$19.9M Sell
899,749
-817,025
-48% -$17.4M 0.04% 416
2016
Q2
$30.7M Buy
1,716,774
+1,044,407
+155% +$18.1M 0.03% 453
2016
Q1
$11.6M Buy
672,367
+86,444
+15% +$1.45M 0.02% 512
2015
Q4
$12.4M Buy
585,923
+50,656
+9% +$1.03M 0.03% 482
2015
Q3
$10.1M Buy
535,267
+109,027
+26% +$2.33M 0.02% 526
2015
Q2
$9.78M Buy
426,240
+64,667
+18% +$1.51M 0.02% 555
2015
Q1
$9.76M Buy
361,573
+76,306
+27% +$1.95M 0.02% 559
2014
Q4
$8.25M Buy
285,267
+65,401
+30% +$1.77M 0.02% 572
2014
Q3
$5.91M Buy
219,866
+48,268
+28% +$1.15M 0.01% 660
2014
Q2
$3.79M Buy
171,598
+20,275
+13% +$466K 0.01% 799
2014
Q1
$4.13M Buy
151,323
+39,637
+35% +$1.16M 0.01% 730
2013
Q4
$3.45M Buy
111,686
+10,625
+11% +$273K 0.01% 745
2013
Q3
$2.87M Sell
101,061
-28,113
-22% -$767K 0.01% 784
2013
Q2
$3.3M Buy
+129,174
New +$3.03M 0.01% 706

Other funds holding QDEL

Macquarie Group's QDEL Position: Q2 2024 in Review

Macquarie Group sold out of QuidelOrtho (QDEL) in Q2 2024, closing a stake of 36,330 shares — an estimated $1.74M sold.

Macquarie Group first reported a position in QDEL in Q2 2013 and held it in 44 quarters. The position peaked at $86.3M in Q1 2020. 261 funds tracked by Wall St. Rank hold QDEL as of Q2 2024.

  • Macquarie Group reported no remaining QuidelOrtho position as of Q2 2024 after selling out during the quarter.
  • Macquarie Group sold 36,330 QuidelOrtho shares in Q2 2024, an estimated $1.74M.
  • Macquarie Group first reported a position in QuidelOrtho in Q2 2013 and held it in 44 quarters.
  • Macquarie Group's QuidelOrtho position peaked at $86.3M in Q1 2020.
  • 261 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.